 SANTA MONICA, Calif., June 17, 2021 GLOBE NEWSWIRE -- BioVie Inc. NASDAQ: BIVI BioVie or Company,a clinical-stage company developing innovative drug therapies for the treatment of liver disease and neurological and neuro-degenerative disorders and certain cancers,, today announced an interview with Cuong Do, CEO of BioVie Inc., will air on The RedChip Money Report on the Bloomberg Network in the U.S. on this coming Saturday, June 19th, at 7 p.m. local time. 